Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST

Conclusion: DPL showed rapid and sustained suppression of systemic and airway type 2 inflammatory biomarkers (including FeNO and IgE) in asthma pts, and was generally well tolerated.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Wenzel, S., Pavord, I. D., Rabe, K. F., Papi, A., Fitzgerald, J. M., Jagerschmidt, A., Brian, W., Dong, Q., Swanson, B. N., Hamilton, J. D., Amin, N., Pirozzi, G., Ruddy, M., Akinlade, B., Graham, N. M. H., Teper, A. Tags: Allergy and immunology Source Type: research